Global Veterinary/Animal Vaccines Market is expected to reach USD 9.75 Billion by 2026 from USD XX Billion in 2019 at CAGR of XX% (Detailed analysis of the market CAGR is provided in the report) The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Veterinary/Animal Vaccines are used to improve health and life expectancies of animals and avoids transmission of diseases from animals to humans. Veterinary/Animal Vaccines are used to improve livestock production in a cost-effective manner. Global Veterinary/Animal Vaccines Market is segmented by type, disease, technology, and geography. Type segment is sub-segmented as livestock vaccines, companion animal vaccines, porcine vaccines, and others. Companion animal vaccines segment is expected to register the highest growth rate during the forecast period. This growth is attributed to rising awareness about companion animal vaccination and the increasing prevalence of zoonotic diseases in humans. Diseases segment is classified as porcine diseases, poultry diseases, livestock diseases, and others. Technology segment is divided as live attenuated vaccines, inactivated vaccines, toxoid vaccines, and others. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing adoption of companion animals and a rising incidence of zoonotic diseases are trending the overall Global Veterinary/Animal Vaccines Market. However, high storage costs for vaccines will restrain market growth. North America is expected to dominate the Veterinary/Animal Vaccines Market in forecast period followed by Europe and APAC. Technologically advanced research and increasing investments in vaccine manufacturing facilities in this region will fuel the Veterinary/Animal Vaccines Market in the North America region. Key Highlights: • Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Veterinary/Animal Vaccines Market analysis and comprehensive segmentation with respect to the type, disease, technology, and geography to assist in strategic business planning • Global Veterinary/Animal Vaccines Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions. Research Methodology: The research methodology used in this report contains various secondary sources including Bloomberg, Hoovers, and Factiva. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Veterinary/Animal Vaccines Market globally. Key Players in the Global Veterinary/Animal Vaccines Market Are: • China Animal Husbandry • Jinyu Bio-Technology • Biogenesis Bago • Tianjin Ringpu • Idt Biologika • Hipra • Phibro Animal Health • Hester • Vetoquinol • Virbac • Ceva • Elanco • Boehringer Ingelheim • Merck Animal Health • Zoetis Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Animal vaccine distributors and wholesalers • Animal vaccine manufacturers • Veterinary clinics and care centers • Animal healthcare product manufacturers • Animal welfare associations • Contract research organizations (CROs) • Government Bodies Scope of the Report: Research report categorizes the Global Veterinary/Animal Vaccines Market based on type, disease, technology, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Veterinary/Animal Vaccines Market with key developments in companies and market trends. Global Veterinary/Animal Vaccines Market, By Type: • Livestock Vaccines • Bovine Vaccines • Small Ruminant Vaccines • Companion Animal Vaccines • Canine Vaccines • Feline Vaccines • Porcine Vaccines • Poultry Vaccines • Aquaculture Vaccines • Other Animal Vaccines Global Veterinary/Animal Vaccines Market, By Disease: • Porcine Diseases • Poultry Diseases • Livestock Diseases • Bovine Diseases • Small Ruminant Diseases • Companion Animal Diseases • Canine Diseases • Feline Diseases • Aquaculture Diseases • Other Diseases Global Veterinary/Animal Vaccines Market, By Technology: • Live Attenuated Vaccines • Inactivated Vaccines • Toxoid Vaccines • Recombinant Vaccines • Other Vaccines Global Veterinary/Animal Vaccines Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.
Table of Contents
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE (2019-2026) 5.1. Introduction 5.2. Livestock Vaccines 5.2.1. Livestock Vaccines Market Overview 5.2.2. Livestock Vaccines Market Size & Forecast 126.96.36.199. Bovine Vaccines 188.8.131.52. Small Ruminant Vaccines 5.3. Companion Animal Vaccines 5.3.1. Companion Animal Vaccines Market Overview 5.3.2. Companion Animal Vaccines Market Size & Forecast 184.108.40.206. Canine Vaccines 220.127.116.11. Feline Vaccines 5.4. Porcine Vaccines 5.4.1. Porcine Vaccines Market Overview 5.4.2. Porcine Vaccines Market Size & Forecast 5.5. Poultry Vaccines 5.5.1. Poultry Vaccines Market Overview 5.5.2. Poultry Vaccines Market Size & Forecast 5.6. Aquaculture Vaccines 5.6.1. Aquaculture Vaccines Market Overview 5.6.2. Aquaculture Vaccines Market Size & Forecast 5.7. Other Animal Vaccines 5.7.1. Other Animal Vaccines Market Overview 5.7.2. Other Animal Vaccines Market Size & Forecast 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY DISEASE (2019-2026) 6.1. Introduction 6.2. Porcine Diseases 6.2.1. Porcine Diseases Market Overview 6.2.2. Porcine Diseases Market Size & Forecast 6.3. Poultry Diseases 6.3.1. Poultry Diseases Market Overview 6.3.2. Poultry Diseases Market Size & Forecast 6.4. Livestock Diseases 6.4.1. Livestock Diseases Market Overview 6.4.2. Livestock Diseases Market Size & Forecast 18.104.22.168. Bovine Diseases 22.214.171.124. Small Ruminant Diseases 6.5. Companion Animal Diseases 6.5.1. Companion Animal Diseases Market Overview 6.5.2. Companion Animal Diseases Market Size & Forecast 126.96.36.199. Canine Diseases 188.8.131.52. Feline Diseases 6.6. Aquaculture Diseases 6.6.1. Aquaculture Diseases Market Overview 6.6.2. Aquaculture Diseases Market Size & Forecast 6.7. Other Diseases 6.7.1. Other Diseases Market Overview 6.7.2. Other Diseases Market Size & Forecast 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY (2019-2026) 7.1. Introduction 7.2. Live Attenuated Vaccines 7.2.1. Live Attenuated Vaccines Market Overview 7.2.2. Live Attenuated Vaccines Market Size & Forecast 7.3. Inactivated Vaccines 7.3.1. Inactivated Vaccines Market Overview 7.3.2. Inactivated Vaccines Market Size & Forecast 7.4. Toxoid Vaccines 7.4.1. Toxoid Vaccines Market Overview 7.4.2. Toxoid Vaccines Market Size & Forecast 7.5. Recombinant Vaccines 7.5.1. Recombinant Vaccines Market Overview 7.5.2. Recombinant Vaccines Market Size & Forecast 7.6. Other Vaccines 7.6.1. Other Vaccines Market Overview 7.6.2. Other Vaccines Market Size & Forecast 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY GEOGRAPHY (2019-2026) 8.1. North America Veterinary/Animal Vaccines Market 8.1.1. North America Veterinary/Animal Vaccines Market, By Type 8.1.2. North America Veterinary/Animal Vaccines Market, By Diseases 8.1.3. North America Veterinary/Animal Vaccines Market, By Application 8.1.4. North America Veterinary/Animal Vaccines Market, by Region 184.108.40.206. U.S. Veterinary/Animal Vaccines Market 220.127.116.11. Canada Veterinary/Animal Vaccines Market 18.104.22.168. Mexico Veterinary/Animal Vaccines Market 8.2. Europe Veterinary/Animal Vaccines Market 8.2.1. Europe Veterinary/Animal Vaccines Market, By Type 8.2.2. Europe Veterinary/Animal Vaccines Market, By Diseases 8.2.3. Europe Veterinary/Animal Vaccines Market, By Application 8.2.4. Europe Global Veterinary/Animal Vaccines Market, by Region 22.214.171.124. France Veterinary/Animal Vaccines Market 126.96.36.199. Germany Veterinary/Animal Vaccines Market 188.8.131.52. U.K. Veterinary/Animal Vaccines Market 184.108.40.206. Italy Veterinary/Animal Vaccines Market 220.127.116.11. Spain Veterinary/Animal Vaccines Market 18.104.22.168. Rest of Europe Veterinary/Animal Vaccines Market 8.3. Asia Pacific Veterinary/Animal Vaccines Market 8.3.1. Asia-Pacific Veterinary/Animal Vaccines Market, By Type 8.3.2. Asia-Pacific Veterinary/Animal Vaccines Market, By Diseases 8.3.3. Asia-Pacific Veterinary/Animal Vaccines Market, By Application 8.3.4. Asia-Pacific Veterinary/Animal Vaccines Market, by Region 22.214.171.124. China Veterinary/Animal Vaccines Market 126.96.36.199. Japan Veterinary/Animal Vaccines Market 188.8.131.52. India Veterinary/Animal Vaccines Market 184.108.40.206. South Korea Veterinary/Animal Vaccines Market 220.127.116.11. Rest of Asia Pacific Veterinary/Animal Vaccines Market 8.4. Middle East & Africa Veterinary/Animal Vaccines Market 8.4.1. Middle East & Africa Veterinary/Animal Vaccines Market, By Type 8.4.2. Middle East & Africa Veterinary/Animal Vaccines Market, By Diseases 8.4.3. Middle East & Africa Veterinary/Animal Vaccines Market, By Application 8.4.4. Middle East & Africa Veterinary/Animal Vaccines Market, by Region 18.104.22.168. South Africa Veterinary/Animal Vaccines Market 22.214.171.124. Rest of Middle East and Africa Veterinary/Animal Vaccines Market 8.5. Latin America Veterinary/Animal Vaccines Market 8.5.1. Latin America Veterinary/Animal Vaccines Market, By Type 8.5.2. Latin America Veterinary/Animal Vaccines Market, By Diseases 8.5.3. Latin America Veterinary/Animal Vaccines Market, By Application 8.5.4. Latin America Veterinary/Animal Vaccines Market, by Region 126.96.36.199. Brazil Veterinary/Animal Vaccines Market 188.8.131.52. Rest of Latin America Veterinary/Animal Vaccines Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 China Animal Husbandry 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Developments 9.3.2 Jinyu Bio-Technology 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Developments 9.3.3 Biogenesis Bago 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Developments 9.3.4 Tianjin Ringpu 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Developments 9.3.5 Idt Biologika 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Developments 9.3.6 Hipra 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Developments 9.3.7 Phibro Animal Health 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.8 Hester 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.9 Vetoquinol 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.10 Virbac 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.11 Ceva 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.12 Elanco 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.13 Boehringer Ingelheim 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.14 Merck Animal Health 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.15 Zoetis 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development